Innoviva, Inc. Indenture Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Indenture (including form of Note) with respect to Innovivas 2.125% Convertible Senior Notes due 2028, dated as of March 7, 2022, between Innoviva and The Bank of New York Mellon...
Indenture Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2022
INNOVIVA, INC. and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee INDENTURE Dated as of August 7, 2017 2.50% Convertible Senior Notes due 2025
Indenture Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2017
AMENDED AND RESTATED INDENTURE dated as of August 3, 2016 by and between LABA ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and...
Indenture Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2016
INDENTURE dated as of April 17, 2014 by and between LABA ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL...
Indenture Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2014
THERAVANCE, INC. 2.125% CONVERTIBLE SUBORDINATED NOTES DUE 2023 INDENTURE DATED AS OF JANUARY 24, 2013 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. AS TRUSTEE
Indenture Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2013
THERAVANCE, INC. 3% CONVERTIBLE SUBORDINATED NOTES DUE 2015 INDENTURE DATED AS OF JANUARY 23, 2008 THE BANK OF NEW YORK TRUST COMPANY, N.A. AS TRUSTEE
Indenture Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2008